The Amyloidosis Channel is supported through an educational grant from Alexion Pharma GmbH.
The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESC 2026 | Key priorities for achieving consistent cardiac amyloidosis care across Europe
Luuk Kieviet, MD, University Medical Center Utrecht, Utrecht, Netherlands, discusses key priorities for reducing variation in cardiac amyloidosis care across Europe. Dr Kieviet highlights persistent differences in diagnosis and treatment despite guideline recommendations, emphasizing the need to better understand infrastructure and resource-related factors to improve patient care and outcomes. This interview took place during the 2026 European Society of Cardiology (ESC) Congress in Munich, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
